Free-cash-flow proxy increased 83.2%
Free-cash-flow proxy changed +83.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed +83.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +65.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed +105.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating margin changed +70783 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross margin changed +13411 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed +280.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed +5751.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Research & development changed -46.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -23388 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Trade receivables changed -27.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Capex / revenue changed +3751 basis points from the comparable as-filed period.
Working capital changed -47.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cost of revenue changed -68.0% from the comparable as-filed period.
Free-cash-flow margin changed +66540 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +70291 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
R&D / revenue changed -7670 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -11762 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current liabilities changed +24.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed -20.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current ratio changed -35.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital / assets changed -1896 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed +5.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -10.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed +817.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Shares outstanding changed from 0 to 17718161 shares in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.